香港股市 已收市

Otsuka Holdings Co., Ltd. (OTSKY)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
20.63+0.17 (+0.86%)
收市：03:59PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價20.45
開市20.48
買盤0.00 x 0
賣出價0.00 x 0
今日波幅20.28 - 20.71
52 週波幅16.04 - 22.00
成交量18,231
平均成交量39,681
市值22.621B
Beta 值 (5 年，每月)0.24
市盈率 (最近 12 個月)25.47
每股盈利 (最近 12 個月)0.81
業績公佈日2024年7月29日 - 2024年8月02日
遠期股息及收益率0.37 (1.78%)
除息日2023年12月28日
1 年預測目標價17.16
  • Benzinga

    Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation

    Otsuka Pharmaceutical Co Ltd (OTC: OTSKF) (OTC: OTSKY) (Otsuka) and H. Lundbeck A/S have received FDA approval for Rexulti (brexpiprazole) for use in the treatment of agitation associated with dementia due to Alzheimer's disease. This approval makes Rexulti the first and only pharmacological treatment approved in the U.S. for agitation associated with dementia due to Alzheimer's disease. It is reported in approximately half of people with Alzheimer's dementia and is associated with earlier nursi